The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is associated with an immunosuppressive tumor‐microenvironment (TME) that supports the growth of tumors and mediates tumors enabling evasion of the immune system. Expression of programmed cell death ligand 1 (PD‐L1) and loss of human leukocyte antigen (HLA) cla...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Imai, Daisuke, Yoshizumi, Tomoharu, Okano, Shinji, Uchiyama, Hideaki, Ikegami, Toru, Harimoto, Norifumi, Itoh, Shinji, Soejima, Yuji, Aishima, Shinichi, Oda, Yoshinao, Maehara, Yoshihiko
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504334/
https://ncbi.nlm.nih.gov/pubmed/28602029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1087
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky